Acrylonitrile Derivatives against Trypanosoma cruzi: In Vitro Activity and Programmed Cell Death Study

The neglected infection known as Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, results in more than 7000 deaths per year, with an increasing number of cases in non-endemic areas such as Europe or the United States. Moreover, with the current available therapy, only two compounds which are active against the acute phase of the disease are readily available. In addition, these therapeutic agents display multiple undesired side effects such as high toxicity, they are expensive, the treatment is lengthy and the resistant strain has emerged. Therefore, there is a need to find new compounds against Chagas disease which should be active against the parasite but also cause low toxicity to the patients. In the present work, the activity of novel acrylonitriles against Trypanosoma cruzi was evaluated as well as the analysis of the physiological events induced in the treated parasites related to the cell death process. Hence, the characteristic features of an apoptosis-like process such as chromatin condensation and mitochondrial membrane potential, among others, were studied. From the 32 compounds tested against the epimastigote stage of T. cruzi, 11 were selected based on their selectivity index to determine if these compounds were able to induce programmed cell death (PCD) in the treated parasites. Furthermore, acrylonitriles Q5, Q7, Q19, Q27 and Q29 were shown to trigger physiological events related in the PCD. Therefore, this study highlights the therapeutic potential of acrylonitriles as novel trypanocidal agents.

Saved in:
Bibliographic Details
Main Authors: Bethencout-Estrella, Carlos J., Delgado-Hernández, Samuel, López-Arencibia, Atteneri, San Nicolás-Hernández, Desirée, Sifaoui, Ines, Tejedor, David, García-Tellado, Fernando, Lorenzo-Morales, Jacob, Piñero, José E.
Other Authors: Ministerio de Ciencia, Innovación y Universidades (España)
Format: artículo biblioteca
Language:English
Published: Multidisciplinary Digital Publishing Institute 2021-06-09
Subjects:Chemotherapy, Trypanosoma, Acrylonitrile, Toxicity, Chagas,
Online Access:http://hdl.handle.net/10261/244470
http://dx.doi.org/10.13039/501100011033
http://dx.doi.org/10.13039/501100007757
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-ipna-es-10261-244470
record_format koha
spelling dig-ipna-es-10261-2444702021-12-27T15:45:17Z Acrylonitrile Derivatives against Trypanosoma cruzi: In Vitro Activity and Programmed Cell Death Study Bethencout-Estrella, Carlos J. Delgado-Hernández, Samuel López-Arencibia, Atteneri San Nicolás-Hernández, Desirée Sifaoui, Ines Tejedor, David García-Tellado, Fernando Lorenzo-Morales, Jacob Piñero, José E. Ministerio de Ciencia, Innovación y Universidades (España) Agencia Estatal de Investigación (España) Universidad de La Laguna Cajasiete Agencia Canaria de Investigación, Innovación y Sociedad de la Información Red de Investigación Cooperativa en Enfermedades Tropicales (España) Chemotherapy Trypanosoma Acrylonitrile Toxicity Chagas The neglected infection known as Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, results in more than 7000 deaths per year, with an increasing number of cases in non-endemic areas such as Europe or the United States. Moreover, with the current available therapy, only two compounds which are active against the acute phase of the disease are readily available. In addition, these therapeutic agents display multiple undesired side effects such as high toxicity, they are expensive, the treatment is lengthy and the resistant strain has emerged. Therefore, there is a need to find new compounds against Chagas disease which should be active against the parasite but also cause low toxicity to the patients. In the present work, the activity of novel acrylonitriles against Trypanosoma cruzi was evaluated as well as the analysis of the physiological events induced in the treated parasites related to the cell death process. Hence, the characteristic features of an apoptosis-like process such as chromatin condensation and mitochondrial membrane potential, among others, were studied. From the 32 compounds tested against the epimastigote stage of T. cruzi, 11 were selected based on their selectivity index to determine if these compounds were able to induce programmed cell death (PCD) in the treated parasites. Furthermore, acrylonitriles Q5, Q7, Q19, Q27 and Q29 were shown to trigger physiological events related in the PCD. Therefore, this study highlights the therapeutic potential of acrylonitriles as novel trypanocidal agents. Projects PI18/01380 FIS, Spanish Ministry of Science, Innovation and Universities, RD16/0027/0001 of the programme of Redes Temáticas de Investigación Cooperativa (RICET), FIS, Spanish Ministry of Science, Innovation and Universities; C.J.B.-E. and D.S.-H. by ACIISI, I.S by RICET, all cofounded by FEDER. Project “Iniciación a la actividad investigadora, 2019” from Universidad de La Laguna (Ministerio de Ciencia e Innovación y Universidades). This research was funded by the Spanish Ministry of Science, Innovation and Universities (MICINN), State Research Agency (AEI) and the European Regional Development Funds (ERDF) (PGC2018-094503-B-C21). S.D.-H. thanks La Laguna University and Cajasiete for a pre-doctoral contract. Peer reviewed 2021-06-23T09:38:32Z 2021-06-23T09:38:32Z 2021-06-09 artículo http://purl.org/coar/resource_type/c_6501 Pharmaceuticals 14(6), 552: 1-19 (2021) http://hdl.handle.net/10261/244470 10.3390/ph14060552 1424-8247 http://dx.doi.org/10.13039/501100011033 http://dx.doi.org/10.13039/501100007757 34207767 en #PLACEHOLDER_PARENT_METADATA_VALUE# MICINN/PGC2018/094503-B-C21 Publisher's version https://doi.org/10.3390/ph14060552 Sí open Multidisciplinary Digital Publishing Institute
institution IPNA ES
collection DSpace
country España
countrycode ES
component Bibliográfico
access En linea
databasecode dig-ipna-es
tag biblioteca
region Europa del Sur
libraryname Biblioteca del IPNA España
language English
topic Chemotherapy
Trypanosoma
Acrylonitrile
Toxicity
Chagas
Chemotherapy
Trypanosoma
Acrylonitrile
Toxicity
Chagas
spellingShingle Chemotherapy
Trypanosoma
Acrylonitrile
Toxicity
Chagas
Chemotherapy
Trypanosoma
Acrylonitrile
Toxicity
Chagas
Bethencout-Estrella, Carlos J.
Delgado-Hernández, Samuel
López-Arencibia, Atteneri
San Nicolás-Hernández, Desirée
Sifaoui, Ines
Tejedor, David
García-Tellado, Fernando
Lorenzo-Morales, Jacob
Piñero, José E.
Acrylonitrile Derivatives against Trypanosoma cruzi: In Vitro Activity and Programmed Cell Death Study
description The neglected infection known as Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, results in more than 7000 deaths per year, with an increasing number of cases in non-endemic areas such as Europe or the United States. Moreover, with the current available therapy, only two compounds which are active against the acute phase of the disease are readily available. In addition, these therapeutic agents display multiple undesired side effects such as high toxicity, they are expensive, the treatment is lengthy and the resistant strain has emerged. Therefore, there is a need to find new compounds against Chagas disease which should be active against the parasite but also cause low toxicity to the patients. In the present work, the activity of novel acrylonitriles against Trypanosoma cruzi was evaluated as well as the analysis of the physiological events induced in the treated parasites related to the cell death process. Hence, the characteristic features of an apoptosis-like process such as chromatin condensation and mitochondrial membrane potential, among others, were studied. From the 32 compounds tested against the epimastigote stage of T. cruzi, 11 were selected based on their selectivity index to determine if these compounds were able to induce programmed cell death (PCD) in the treated parasites. Furthermore, acrylonitriles Q5, Q7, Q19, Q27 and Q29 were shown to trigger physiological events related in the PCD. Therefore, this study highlights the therapeutic potential of acrylonitriles as novel trypanocidal agents.
author2 Ministerio de Ciencia, Innovación y Universidades (España)
author_facet Ministerio de Ciencia, Innovación y Universidades (España)
Bethencout-Estrella, Carlos J.
Delgado-Hernández, Samuel
López-Arencibia, Atteneri
San Nicolás-Hernández, Desirée
Sifaoui, Ines
Tejedor, David
García-Tellado, Fernando
Lorenzo-Morales, Jacob
Piñero, José E.
format artículo
topic_facet Chemotherapy
Trypanosoma
Acrylonitrile
Toxicity
Chagas
author Bethencout-Estrella, Carlos J.
Delgado-Hernández, Samuel
López-Arencibia, Atteneri
San Nicolás-Hernández, Desirée
Sifaoui, Ines
Tejedor, David
García-Tellado, Fernando
Lorenzo-Morales, Jacob
Piñero, José E.
author_sort Bethencout-Estrella, Carlos J.
title Acrylonitrile Derivatives against Trypanosoma cruzi: In Vitro Activity and Programmed Cell Death Study
title_short Acrylonitrile Derivatives against Trypanosoma cruzi: In Vitro Activity and Programmed Cell Death Study
title_full Acrylonitrile Derivatives against Trypanosoma cruzi: In Vitro Activity and Programmed Cell Death Study
title_fullStr Acrylonitrile Derivatives against Trypanosoma cruzi: In Vitro Activity and Programmed Cell Death Study
title_full_unstemmed Acrylonitrile Derivatives against Trypanosoma cruzi: In Vitro Activity and Programmed Cell Death Study
title_sort acrylonitrile derivatives against trypanosoma cruzi: in vitro activity and programmed cell death study
publisher Multidisciplinary Digital Publishing Institute
publishDate 2021-06-09
url http://hdl.handle.net/10261/244470
http://dx.doi.org/10.13039/501100011033
http://dx.doi.org/10.13039/501100007757
work_keys_str_mv AT bethencoutestrellacarlosj acrylonitrilederivativesagainsttrypanosomacruziinvitroactivityandprogrammedcelldeathstudy
AT delgadohernandezsamuel acrylonitrilederivativesagainsttrypanosomacruziinvitroactivityandprogrammedcelldeathstudy
AT lopezarencibiaatteneri acrylonitrilederivativesagainsttrypanosomacruziinvitroactivityandprogrammedcelldeathstudy
AT sannicolashernandezdesiree acrylonitrilederivativesagainsttrypanosomacruziinvitroactivityandprogrammedcelldeathstudy
AT sifaouiines acrylonitrilederivativesagainsttrypanosomacruziinvitroactivityandprogrammedcelldeathstudy
AT tejedordavid acrylonitrilederivativesagainsttrypanosomacruziinvitroactivityandprogrammedcelldeathstudy
AT garciatelladofernando acrylonitrilederivativesagainsttrypanosomacruziinvitroactivityandprogrammedcelldeathstudy
AT lorenzomoralesjacob acrylonitrilederivativesagainsttrypanosomacruziinvitroactivityandprogrammedcelldeathstudy
AT pinerojosee acrylonitrilederivativesagainsttrypanosomacruziinvitroactivityandprogrammedcelldeathstudy
_version_ 1777669891867803648